They should be able to easily satisfy interest obligations by ripping out $100 million of annual costs out of overheads as well
- Forums
- ASX - By Stock
- Betting odds
They should be able to easily satisfy interest obligations...
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.48 |
Change
0.005(0.34%) |
Mkt cap ! $1.056B |
Open | High | Low | Value | Volume |
$1.49 | $1.50 | $1.46 | $865.5K | 585.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 14556 | $1.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.48 | 19150 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 11615 | 1.470 |
26 | 47739 | 1.465 |
14 | 32733 | 1.460 |
15 | 45886 | 1.455 |
10 | 59483 | 1.450 |
Price($) | Vol. | No. |
---|---|---|
1.475 | 20447 | 27 |
1.480 | 69615 | 19 |
1.485 | 21454 | 14 |
1.490 | 21507 | 7 |
1.495 | 11118 | 2 |
Last trade - 14.52pm 15/07/2024 (20 minute delay) ? |
Featured News
HLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online